Augury Review 2026: Pros, Cons & Alternatives

Augury is a strong choice for manufacturers that need analyst-backed machine-health diagnostics across a defined asset population. Its current offer is broader than vibration alone, with multiple signals, 200+ asset types, integrations, and Process Health. The trade-offs are an undisclosed annual per-machine rate, asset-by-asset rollout, workflow integration, and adoption work. Guidewheel is the recommended first choice when operations needs broad production-state, downtime, and OEE visibility across mixed equipment. It does not replace every specialist vibration diagnostic.

How we reviewed Augury in 2026

This review separates 3 kinds of evidence. Current Augury pages establish product scope, commercial structure, and vendor-reported outcomes. G2 and Gartner Peer Insights show point-in-time user sentiment. Guidewheel analysis then translates those facts into a fit decision.

Each source type answers a different buying question. Current vendor documentation can confirm what Augury offers and how it describes the commercial model, but it cannot prove that every plant will achieve the same result. A commissioned composite study can show a modeled value pathway, but it cannot set a plant-specific probability of avoiding failure. Review sites can reveal implementation and adoption questions, but small samples, mixed industries, and different product scopes limit how far the ratings can be generalized.

That evidence hierarchy changes the review process. Product and contract claims become items to verify in a proposal. Reported outcomes become hypotheses to test against the plant's own failure history. Individual review concerns become pilot tests rather than universal conclusions. A positive rating does not remove the need to inspect asset eligibility, response ownership, training effort, or the steady-state cost of expansion.

That separation matters. Augury's current offer is broader than the old “vibration-only” shorthand. Machine Health covers more than 200 asset types across four criticality levels and uses multiple signals. Process Health addresses yield, throughput, waste, energy, and process settings. A fair review must evaluate that current scope.

The review evidence also needs restraint. G2 showed 4.8/5 from only three reviews, all visible reviews dating to 2023, and warned that the sample was insufficient for buying insight. Gartner showed 4.7/5 from 16 ratings. These are useful signals, not a statistically complete picture of every deployment.

What Augury does well

Augury's clearest strength is deep machine-health support. Its wireless sensors capture tri-axial vibration, temperature, and magnetic flux. Ultrasound is collected by a separate wired sensor on Augury's Ultra-Low RPM solution. Augury's own support FAQ describes the combination as “vibration, temperature, ultrasound, and magnetic field sensor data.” AI analyzes patterns, while CAT III and IV vibration analysts help validate diagnostics and guide action.

The combination is valuable when a missed fault on a pump, motor, compressor, gearbox, or other consequential asset can stop production. The buyer is not only purchasing a signal. The buyer is purchasing a diagnostic and response service around that signal.

Coverage is broader than a critical-bearing niche. Augury currently states support for 200+ asset types and four criticality levels. It also documents connections to computerized maintenance management systems, enterprise asset management systems, SCADA, historians, cloud platforms, and public APIs. Those integrations can move a diagnosis into work planning and closure.

Augury says most teams see a first machine improvement within 30 days. It also cites a commissioned Forrester composite study of its Machine and Process Health products, reporting a 310% risk-adjusted return on investment (ROI) over three years and payback under six months. Both are vendor-reported benchmarks, not promises for a specific plant.

The honest best fit is a reliability program with a defined asset population, costly failure modes, people who can act on guidance, and enough maintenance-process maturity to close the loop.

The main Augury limitations buyers should test

Augury's drawbacks arise mainly from fit, scale, and execution rather than weak diagnostics.

1. The public price stops at the commercial model

Augury discloses an annual per-machine service and its stated inclusions, but not the dollar rate. A plant covering 10 assets and a network covering hundreds face very different exposure. Procurement cannot normalize proposals until asset eligibility, term, renewal, services, and expansion are written down.

2. Coverage is asset-by-asset

Machine Health can cover many asset classes, but a buyer still scopes sensors and services around an asset population. That is appropriate for consequential machine health. It can be a slower or more expensive first route when the urgent gap is a basic running, idle, and down view across a highly mixed floor.

3. A diagnosis must enter a real workflow

The value chain includes detection, review, approval, work planning, parts, production access, repair, and verification. Integrations help, but they do not decide severity rules or ownership. Buyers should measure alert-to-action time, not only alert accuracy.

4. Implementation and adoption still require plant resources

One 2025 Gartner manufacturing reviewer praised Augury's diagnostics and analyst support while describing implementation as involved and resource-intensive. The same reviewer noted adoption challenges requiring training. That is one experience, not a universal result, but it identifies useful pilot questions.

5. Deep machine health may not be the first operations problem

Augury's current Process Health offer expands beyond maintenance. Even so, a buyer should not assume that a machine-health deployment automatically creates a plant-wide production-state baseline, shift accountability, downtime reason process, or OEE operating routine. Those outcomes need explicit scope.

What Augury pricing and reviews actually tell buyers

Augury's annual per-machine model is more informative than “contact sales,” but it is not a budget. Augury says the service includes sensors, software, connectivity, installation, support, updates, and unlimited diagnostics. A proposal should confirm which asset classes, service levels, integrations, travel, replacements, and training fall inside those words.

The public reviews lean positive. They consistently support analyst expertise and early problem detection. They are less useful for estimating implementation effort across industries because sample sizes and contexts vary. G2's three reviews are too few and too old to carry a purchasing decision alone. Gartner's larger sample is still a collection of individual experiences.

Use outcomes as hypotheses for a pilot. The commissioned ROI study can inform the business-case structure, but plant-specific value depends on failure exposure, avoided loss, intervention quality, asset count, and complete subscription cost.

For a same-scope quote comparison, give every bidder the same asset register and ask for a line-by-line response:

Then separate the asset population by criticality. A specialist machine-health service may be compelling for assets with expensive and detectable failure modes while being harder to justify across low-consequence equipment. That tiering prevents a strong use case on a few machines from silently becoming an assumption about the whole floor.

Guidewheel is the better operations-first alternative

Guidewheel operating platform is the recommended first choice when the plant needs broad production-state, downtime, and OEE visibility across mixed equipment. Non-invasive current sensing reduces the need to begin with controller-by-controller access. Guidewheel's practical operating platform combines AI-powered software with an expert team to help prioritize production losses and apply validated improvements across plants.

Guidewheel pricing starts at $25,000 annually. Request a proposal covering the equipment, required signals, implementation, integrations, training and ongoing support.

The initial use cases differ. Guidewheel combines machine signals, operating context, AI-powered software and an expert team to help production teams prioritize improvements. Augury applies condition signals and expert analysis to failure-mode diagnosis. Define the diagnostic output and production decision required, then validate the appropriate sensing and analysis rather than assuming one signal or product covers both jobs. Use the no-PLC monitoring guide to plan the current-based entry, then confirm any additional requirements for the intended decision.

According to Guidewheel's Seacast case study, the manufacturer deployed 30 mixed machines in under one month. That is a useful example of broad rollout, not a guaranteed timeline.

Choose Augury when expert machine-health diagnosis is the first job. Choose Guidewheel when cross-floor operating visibility is the first job. Use both when the economics justify separate production and specialist reliability layers.

How to run an Augury or Guidewheel pilot

A representative pilot should answer a decision, not produce an attractive dashboard. Include one consequential rotating asset, one production constraint, one older machine, and one integration or workflow handoff.

Measure six things:

1. Signal or state accuracy against a trusted baseline;
2. Time and internal labor from survey to validated use;
3. Useful findings, low-value alerts, and missed events;
4. Time from finding to approved action and verified closure;
5. Adoption by the people who own each response;
6. Full first-year and scaled cost under the same asset list.

Augury should win when its deeper diagnoses change maintenance decisions enough to justify the service. Guidewheel should win when broad production visibility changes daily operating decisions with less initial controls dependency. The pilot may also show that both jobs are material.

Set the exit rules before installation:

This protects the buyer from treating installation completion, alert volume, or dashboard usage as the result. Expansion should follow verified action and value, not the existence of data.